UCapital NewsBusiness Super App · news connected to data, companies, people and deals
IT
VoicesWire
LIVE
BREAKING LIVE

The news moving markets, right now

From international newswires in real time. For every story the News Impact AI agent estimates the market impact and flags the assets to watch, with the story’s impact on each: positive, negative or neutral.

STORIES TODAY
27
via finance.yahoo.comBusiness & Companies

Amgen and AstraZeneca report positive Phase 3 TEZSPIRE results in eosinophilic esophagitis

FROM THE WIRE · FINANCE.YAHOO.COM

Amgen (NasdaqGS:AMGN) and AstraZeneca reported positive full Phase 3 results for TEZSPIRE in eosinophilic esophagitis (EoE). The Phase 3 trial showed significant and clinically meaningful improvements in EoE symptoms and endoscopic endpoints sustained through one year.…

Read at the source ↗
MARKET IMPACTNEUTRAL✦ News Impact agent estimateTone: expected bullishPositive Phase 3 data in a new indication can support Amgen's pipeline, though the price impact is likely limited.AI-generated summary
✦ IN BRIEF · AIAI-generated summary
  1. 01Amgen and AstraZeneca reported positive full Phase 3 results for TEZSPIRE in eosinophilic esophagitis.
  2. 02The trial showed significant improvements in EoE symptoms and endoscopic endpoints sustained through one year.
  3. 03Investigators reported a favorable safety profile in a population with limited treatment options.
NEWS IMPACT AND MARKET REACTIONChange since the story · reference
Amgen Inc.AMGNStock439.26 USDMarket closedtoday -1.79%Positive AstraZeneca PLCAZNStock171.49 USDMarket closedtoday -0.63%Positive
Impact and summary are estimates by the News Impact AI agent, not financial advice.Open in Markets

ALL BREAKING TODAY

Breaking live stories come from third-party newswires via feed; headline and summary belong to the stated source. Impact analysis: UCapital AI · News Impact.

UCapital News is the news section of UCapital24 S.p.A. All content is for information purposes only and does not constitute financial advice, a recommendation or a solicitation to invest. Even where terms such as “buy”, “sell”, “bullish” or “bearish”, or asset impact signals, appear, they only indicate the possible effect of a news item on the markets and are not an invitation to buy or sell financial instruments. News is analysed with UCapital AI and may also be published via API feeds from third-party providers, to give our users a continuous flow of news. UCapital24 S.p.A. accepts no liability of any kind for decisions made on the basis of this content. Wire releases are published by companies and are not verified by the newsroom.

AI use policy. UCapital AI supports the newsroom with news analysis, summaries, market reactions, translations and the generation of cards and charts. AI-generated or AI-assisted content is labelled in the byline (AI Desk, a named AI profile marked «AI», or joint byline) and is reviewed by editors before publication. News received via API feeds from third-party providers is attributed to the original source. AI can make mistakes: report any inaccuracies to the newsroom. Users’ personal data is not used to train the models.